Press releases

Research Use Only (RUO) assay now globally available for BD MAX™ System FRANKLIN LAKES, N.J., Sept. 26, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global...

Announcement Made at Clinton Global Initiative 2022 Commits $360,000 to Support Nurses in Africa FRANKLIN LAKES, N.J., Sept. 19, 2022 /PRNewswire/ -- The BD Foundation, the philanthropic arm of...

BD EffivaxTM Glass Prefillable Syringe Features Enhanced Technology that Builds on Company's Decades of Expertise in the Prefillable Syringe Market and Supports Customers' Manufacturing Needs...

Puneet Sarin Named President of Medication Management Solutions Steve Conly Named President of Biosciences FRANKLIN LAKES, N.J. (Sept. 8, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX),...

Mike Garrison Named EVP and President, Medical segment Rick Byrd Named EVP and President, Interventional segment FRANKLIN LAKES, N.J., Aug. 25, 2022 /PRNewswire/ -- BD (Becton, Dickinson and...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2022 Healthcare Conference on Wednesday,...

Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the consideration payable in connection with its previously announced Tender Offers (as defined below) to purchase...

Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the early tender results for its previously announced Tender Offers (as defined below) to purchase for cash...

First patient enrollment in PREVISION trial marks opportunity to further advance the safety and performance of drug-coated balloon technology and aligns with the company’s commitment to...

Companies will work together to bring rapid antimicrobial identification and susceptibility diagnostics to more clinicians and patients worldwide FRANKLIN LAKES, N.J. and TUCSON, Ariz., Aug. 15,...